Blood Ves­sels

This group of medicinal products includes the various sections of blood vessels or tissues form blood vessels of the human body which can be transplanted.

Name Mar­ket­ing Au­tho­ri­sa­tion Hold­er Li­cense Num­ber Li­cense Date Further Information

Hu­man Vas­cu­lar Tis­sue, cry­op­re­served, BST Barcelona / ETB-BIS­LIFE

BIS­LIFE Foun­da­tion, Nieder­lande

PEI.G.04125.01.1 06.02.2012

Hu­man Vas­cu­lar Tis­sue, cry­op­re­served, ETB-BIS­LIFE

Sticht­ing ETB-BIS­LIFE, NL

PEI.G.04131.01.1 03.02.2012

Hu­man-Blut­ge­fäß, kryokon­serviert, Char­ité

Char­ité – Uni­ver­sitätsmedi­zin Berlin

PEI.G.04021.01.1 23.12.2011

Hu­mane Gefäße, kryokon­serviert, Eu­ropäis­che Herzk­lap­pen­bank Brüs­sel

Eu­ro­pean Ho­mo­graft Bank (E.H.B.), Brüs­sel

PEI.B.04099.01.1 15.01.2012

Hu­manes Blut­ge­fäß, kryokon­serviert, HDZ-NRW (hge­fkryo HDZ NRW)

Herz- und Di­a­beteszen­trum NRW, Bad Oeyn­hausen

PEI.G.03712.01.1 23.12.2011

Hu­manes Blut­ge­fäß, kryokon­serviert, KVGB, Char­ité

Char­ité - Uni­ver­sitätsmedi­zin Berlin KöR - In­sti­tut für Trans­fu­sions-medi­zin, Uni­ver­sitäts-gewe­be­bank (UGB)

PEI.G.04106.01.1 12.01.2012

Hu­manes Gefäß, kryokon­serviert, Han­nover-DGFG

Deutsche Gesellschaft für Gewe­be­trans­plan­ta­tion – Gemein­nützige Gesellschaft mbH – (DGFG), Han­nover

PEI.G.04020.01.1 23.12.2011

NerV­FIX, hu­manes in­vertiertes Nabelschnur­blut­ge­fäß, getrock­net

TBF Génie Tis­su­laire, Frankre­ich

PEI.G.12029.01.1 30.11.2020

Zell­freie hu­mane Aor­ta, Arise AT

cor­life oHG, Han­nover

PEI.G.11996.01.1 01.07.2019

Zell­freier hu­man­er Trun­cus pul­monalis, Es­poir TP

cor­life oHG, Han­nover

PEI.G.11932.01.1 14.08.2018



The list of medicines contains the products that have a valid marketing authorization. It contains no information as to whether the preparations are available on the market.

The information contained in the Federal Gazette, which is the official publication organ of the Paul-Ehrlich-Institut, is legally binding.

As of: PEI announcement No. 477 in BAnz AT 16.02.2021 B7.

Summary of Product Characteristics (SmPCs) and the Package Leaflet (PL)

Where the European Medicines Agency (EMA) offers further information, you will find a link to the EPAR (European public assessment report) in the table.

If user and technical information or public assessment reports are available in PharmNet.Bund, the Federal and State Pharmaceutical Information Portal, these are directly linked to PharmNet.Bund in the table.

Updated: 01.03.2021